|
Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls
RECRUITINGPhase 2Sponsored by University Hospital, Basel, Switzerland
Actively Recruiting
PhasePhase 2
SponsorUniversity Hospital, Basel, Switzerland
Started2025-05-16
Est. completion2027-02
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06676774
Summary
This study aims to investigate the potential beneficial effects of intranasal oxytocin compared to placebo on emotion recognition and acute psychosocial stress in patients with arginine vasopressin deficiency compared to matched healthy controls.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion criteria healthy controls 1. Adult healthy volunteers 2. Matched for age, sex, BMI, and oestrogen replacement/menopause/hormonal contraceptives to patients. 3. No medication, except hormonal contraception Inclusion criteria 1. Adult patients with a confirmed diagnosis of AVP deficiency based on accepted criteria6 2. Stable hormone replacement therapy for at least three months with desmopressin and, in case of additional anterior pituitary deficiencies, with the respective substitution therapies. Exclusion criteria 1. Participation in a trial with investigational drugs within 30 days 2. Active substance use disorder within the last six months 3. Consumption of alcoholic beverages \>15 drinks/week 4. Current or previous psychotic disorder (e.g., schizophrenia spectrum disorder) 5. Pregnancy and breastfeeding within the last eight weeks
Conditions3
Arginine Vasopressin DeficiencyDiabetesDiabetes Insipidus
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorUniversity Hospital, Basel, Switzerland
Started2025-05-16
Est. completion2027-02
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06676774